Compare · BLLN vs CI
BLLN vs CI
Side-by-side comparison of BillionToOne Inc. (BLLN) and The Cigna Group (CI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BLLN and CI operate in Medical Specialities (Health Care), so they compete in similar markets.
- CI is the larger of the two at $72.64B, about 18.6x BLLN ($3.90B).
- Over the past year, BLLN is down 22.5% and CI is down 17.7% - CI leads by 4.8 points.
- CI has been more active in the news (14 items in the past 4 weeks vs 3 for BLLN).
- CI has more recent analyst coverage (25 ratings vs 8 for BLLN).
- Company
- BillionToOne Inc.
- The Cigna Group
- Price
- $85.07+1.25%
- $275.55-1.49%
- Market cap
- $3.90B
- $72.64B
- 1M return
- +10.49%
- +1.90%
- 1Y return
- -22.47%
- -17.71%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- News (4w)
- 3
- 14
- Recent ratings
- 8
- 25
The Cigna Group
Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Latest BLLN
- SEC Form DEFA14A filed by BillionToOne Inc.
- SEC Form DEF 14A filed by BillionToOne Inc.
- BillionToOne to Report First Quarter 2026 Financial Results on May 6, 2026
- BillionToOne Appoints Dr. Allen Chen as Vice President of Medical Affairs and Clinical Development, Oncology
- SEC Form 10-K filed by BillionToOne Inc.
- BillionToOne Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
- BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance
- SEC Form SCHEDULE 13G filed by BillionToOne Inc.
- BillionToOne to Report Fourth Quarter and Full Year 2025 Financial Results on March 4, 2026
- SEC Form SCHEDULE 13G filed by BillionToOne Inc.
Latest CI
- Director Foss Eric J was granted 782 shares, increasing direct ownership by 2% to 36,696 units (SEC Form 4)
- Director Mcclellan Mark B. was granted 782 shares, increasing direct ownership by 13% to 6,891 units (SEC Form 4)
- Director Zarcone Donna F was granted 782 shares, increasing direct ownership by 3% to 27,517 units (SEC Form 4)
- Director Hathi Neesha was granted 782 shares, increasing direct ownership by 23% to 4,151 units (SEC Form 4)
- Director Mazzarella Kathleen M was granted 782 shares, increasing direct ownership by 13% to 6,891 units (SEC Form 4)
- Director Kurian George was granted 782 shares, increasing direct ownership by 21% to 4,560 units (SEC Form 4)
- Director Ross Kimberly A. was granted 782 shares, increasing direct ownership by 17% to 5,294 units (SEC Form 4)
- Director Hennigan Michael J was granted 782 shares, increasing direct ownership by 138% to 1,350 units (SEC Form 4)
- Director Ozuah Philip was granted 782 shares, increasing direct ownership by 43% to 2,583 units (SEC Form 4)
- Director Wiseman Eric C was granted 782 shares, increasing direct ownership by 3% to 23,940 units (SEC Form 4)